Pce toecertn plas!a Ifpcprotedn ard hepa t dc liposes and serun cam1t1ne in newt<m in fants during parenteral 
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I.1poprote1n ard hepat dc lipase activities in postheparin plas!a of p-eters infllnts. L. Pl:NN'fY' . E.A. lillOCIIA·.
K.O. RAIVIO. O111dren' s lb<\:>ital ard IIIrd llepartzI8lt of Medicine, lhiversity of Helsirld. , finlard fat tolerance tests _ t that the dispooal of lipids Infused re sl"""" in pr'eterm than tenn Infanta, "!his has been attriwted to low Ifpcprotem lipase activity because postheparin lipolytic activity (PILA) has been fCU1d to be lOW iri v.ry:l~t WantS ;
Hepatic lipase, oo.ever, acccenta fer abo.lt 7O'J, of FIllA, toIlid> lIB!<es PILAan inadeq.ate ""'SJI'e of Ijpcp-ctein lipase. With specific ...thods we measured lipoprotein lipase and hepat dc lipase activities in postheparin plasm of eleven pretenn neonates . mood saoples were taken fiftee1 mirute:l after-a~in bolus of 100 nJlI<8 given before an excl>lnge transt\lsion perfCll'fll'd with fresh~in1zed blood because of hyperbilinbinem1a. blood 111'"0-4' i.ncx:Iq:atibility er sepsis . The infants were 1 -~daY s old and had b1r-th wel$1ts ( range 1210-3490 1!Jtl) appr-cpriate fer gestational age (range 28-36 weeks) . E181t infants (111'"0-4' t) were in gxxl clinical oorxI1tion ..mle three infants (gr-oll> 2) roffered trcm septic shock. In gr-oll> 1 l ipcpro te in ard hepatic lipase activities were zrard~Jzrol ffAimllh ; both are hijltler than th e activi ties f"""" in tenn intants (!bYam et 01. 1984 Ped1atr . Res. in press) . In !\1'0'-4> 2 J!.poprote1n ard hel»tic lipase activities were 1.8 ard 11)=1 ffA! ml/h; both are considerably u.",,-than the activi t i es f"""" in~1. Q.r l'e3J1ts indicate that lipcprote1n lipase is not the reason fer slow clmr-ance of tat tran the ciro..l1ation in pretenn infants excEPt in septic shock . 33, 435 (1978) reported t hat the treatment \'li t h dextra-t hy roxi ne (OT 4) re sulted in n~rmalization of li ver size , t r i glyce ri de con cen tration and t ransamin as e activ it ies in serum of f our boys with GSO VI a . He t re ated thre e patients \'lith GSD VIa over peri od s of 39, 19 and 18 mont hs respec tively with 60-330 \1g DT4 per kg b .I". per day. In two patient s liver height (sonographi c al l y me asured in th e r i ght medioc l avicu lar l ine ) decreas ed by s even and five cm respectively. Glyco gen co ncentI'ation in erythroc ytes also diminishe d accordingly in t hese patients . Clinical re s f10ns e in one of these h lo pat i en t s was re markable shmd ng a decI'eas e i n t ransami nase ac t ivit ies , trigl yceride levels in serum as wel l as an i nc re as e in growth dur ing t he t rea t ment. Howe ve r , t her e was no signi ficant act i vat ion o f PK i n er yt hro c yt es by OT 4 in all th ree patients . Thi s i ndividual di f ferenc e i n I'esp~m s es to 01 4 tre atment in GSD VIa may be due t o he teroge neity of t his di s ea se. It is nece s sary to s tu dy fur t he I' th e pos sible hete rogene i ty of t his disea s e i n order t o apply efficiently and c orr ectl y DT 4 in the t reatmen t of GSD VIa. 
